header-logo header-logo

03 July 2026 / Mário Barroso
Issue: 8168 / Categories: Features , Family , Health
printer mail-detail

*Partner copy* Hair drug testing: Patterns of use, single events and limitations

253827
© TATIANA KIM/Adobe Stock

Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing and why it remains the gold standard for evidencing patterns of drug use in family proceedings

Hair drug testing occupies a unique position in forensic toxicology. Unlike urine or oral fluid (saliva) – which detect only recent consumption – hair analysis provides a retrospective record of drug exposure spanning weeks or months. This makes it a particularly powerful tool in family court proceedings, where establishing patterns of behaviour is often central to safeguarding decisions.

A question nonetheless arises with increasing frequency: can hair analysis also identify a single episode of use? The answer is nuanced and understanding it is essential for anyone instructing or interpreting hair drug tests.

How hair drug testing works

When a person consumes a drug, the substance enters the bloodstream and small amounts become incorporated into the hair shaft as it grows.

Hair grows at an average rate of approximately 1cm per month. A 3cm sample taken close to the scalp reflects approximately three months, while longer samples extend the detection window accordingly (up to 12 months for a 12cm sample).

Samples can also be segmented into 1cm sections, enabling month-by-month analysis that can reveal patterns such as escalating use, periods of abstinence, or relapse. This sets hair apart from other sample types, making it particularly well-suited to the evidential demands of family proceedings.

Why hair testing is the gold standard for evidencing patterns of use

Where a substance is consumed over weeks or months, repeated incorporation into the hair shaft produces a consistent and detectable pattern that is difficult to dispute.

Hair drug testing is routinely used to evidence long-term or habitual use, demonstrate abstinence, assess adherence to or misuse of prescribed medications, and corroborate or challenge self-reported substance use histories, providing longer-term context where urine or oral fluid results are no longer informative.

Can hair testing identify one-time use?

Where a substance is consumed at a sufficient dose, and where the laboratory’s instrumentation is sensitive enough to detect it, a single consumption event may be identifiable.

This can be relevant in suspected drug-facilitated incidents, where urine and oral fluid samples may no longer contain detectable levels or, for example, in safeguarding cases, where professionals need to determine whether a child’s exposure was isolated or ongoing, or in family proceedings where a disputed allegation – such as a claimed relapse or accidental ingestion – requires objective scrutiny.

However, a negative result does not definitively exclude isolated exposure; an important distinction for legal professionals to understand when instructing hair tests.

Understanding the limitations

Whether a single consumption event is detectable depends on the substance type, dose consumed, individual metabolism, and hair characteristics, including colour and cosmetic treatments.

A low-dose, one-time consumption may fall below detection limits, producing a negative result that does not in itself confirm abstinence.

Hair test results should therefore always be considered alongside clinical, behavioural, and investigative information as part of a wider evidential framework.

Building the most complete evidential picture

Hair analysis is most powerful when combined with narrow-window tests such as oral fluid or urine drug testing. This multi-matrix approach allows an assessment of both recent and historical exposure, cross-verification of findings, and the building of a more complete behavioural profile for the court.

At AlphaBiolabs, we offer the UK’s most comprehensive portfolio of legally-instructed drug and alcohol testing services, backed by over 20 years’ experience supporting family law professionals, social workers and local authorities.

We are UKAS 17025-accredited, with Lab 51 extension for toxicology, and offer free sample collection for legally-instructed tests at our nationwide walk-in centres.

To request a quote or discuss the requirements of your particular case, contact our New Enquiry team on 0333 600 1300, email testing@alphabiolabs.com, or complete our online quote form at https://www.alphabiolabs.co.uk/legal-test-forms/.


 

Mário Barroso, Head of R&D and Method Development at AlphaBiolabs
Mário leads AlphaBiolabs’ technical team on developing and improving testing methods.
Prior to joining AlphaBiolabs, Mário spent 20 years as a Forensic Toxicologist at the Portuguese National Institute of Forensic Medicine, where he developed and implemented hair testing services.
He also sits on the Administration Board of the Society of Hair Testing.

MOVERS & SHAKERS

Taylor Rose—Jacqui Hayat & Andrew Bentham

Taylor Rose—Jacqui Hayat & Andrew Bentham

Taylor Rose strengthens Medical Negligence team with senior leadership appointments

Birmingham Law Society—Sabina Kauser

Birmingham Law Society—Sabina Kauser

Ward Hadaway partner appointed Vice President of Birmingham Law Society

Excello Law—Nick Gore & Irfan Ali

Excello Law—Nick Gore & Irfan Ali

Excello Law immigration boost with two more hires from Irwin Mitchell

NEWS
Developers in areas with poorly performing councils can apply directly to the Planning Inspectorate for permission under section 62A of the Town and Country Planning Act 1990
A divorced woman has secured funding to participate in her former husband’s inquest after the Legal Aid Agency reconsidered repeated refusals
When does a solicitor’s retainer become a contentious business agreement? The Court of Appeal’s decision in Broadfield Law UK LLP v Barnes shows that listing hourly rates alone will not do, leaving firms and clients uncertain about their rights over bills
The Thirlwall Inquiry has exposed a ‘complete failure’ to protect babies at the Countess of Chester Hospital, but its recommendations must now be put into practice
MPs cannot simply resign their Commons seats. Instead, they take a nominal Crown office, usually the Chiltern Hundreds or Manor of Northstead, which disqualifies them from sitting
back-to-top-scroll